372 related articles for article (PubMed ID: 15742638)
1. Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints.
Roth JA
Dev Biol (Basel); 2004; 119():267-72. PubMed ID: 15742638
[TBL] [Abstract][Full Text] [Related]
2. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
3. The use of vaccines in South American foot-and-mouth disease eradication programmes.
Saraiva V; Darsie G
Dev Biol (Basel); 2004; 119():33-40. PubMed ID: 15742616
[TBL] [Abstract][Full Text] [Related]
4. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
[TBL] [Abstract][Full Text] [Related]
5. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle.
Paton DJ; de Clercq K; Greiner M; Dekker A; Brocchi E; Bergmann I; Sammin DJ; Gubbins S; Parida S
Vaccine; 2006 Oct; 24(42-43):6503-12. PubMed ID: 16872727
[TBL] [Abstract][Full Text] [Related]
6. Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America.
Bergmann IE; Malirat V; Falczuk AJ
Expert Rev Vaccines; 2005 Dec; 4(6):903-13. PubMed ID: 16372885
[TBL] [Abstract][Full Text] [Related]
7. Making a vaccinate-to-live policy a reality in foot-and-mouth disease.
Mackay D; Parida S; Paton D; Anderson J
Dev Biol (Basel); 2004; 119():261-6. PubMed ID: 15742637
[TBL] [Abstract][Full Text] [Related]
8. [Point of view of KNMvD concerning foot and mouth disease marker vaccine].
van Leeuwen JM
Tijdschr Diergeneeskd; 2001 Sep; 126(17):585. PubMed ID: 11596520
[No Abstract] [Full Text] [Related]
9. Foot-and-Mouth disease control using vaccination: the Dutch experience in 2001.
Pluimers FH
Dev Biol (Basel); 2004; 119():41-9. PubMed ID: 15742617
[TBL] [Abstract][Full Text] [Related]
10. [Vaccination against foot and mouth disease: a biotechnical approach?].
Moormann RJ
Tijdschr Diergeneeskd; 2001 Dec; 126(24):785-7. PubMed ID: 11780258
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis of foot and mouth disease].
Haas B
Dtsch Tierarztl Wochenschr; 2001 Dec; 108(12):508-13. PubMed ID: 11822165
[TBL] [Abstract][Full Text] [Related]
12. [Vaccination against foot and mouth disease: current state and perspectives].
Visser N; Thiel HJ
Dtsch Tierarztl Wochenschr; 2001 Dec; 108(12):522-5. PubMed ID: 11822168
[TBL] [Abstract][Full Text] [Related]
13. Vaccination as a control measure during the outbreak of foot-and-mouth disease in 2000 in Korea.
Park JH; Park JY; Kim YJ; Oem JK; Lee KN; Kye SJ; Joo YS
Dev Biol (Basel); 2004; 119():63-70. PubMed ID: 15742619
[TBL] [Abstract][Full Text] [Related]
14. Foot-and-mouth disease: the question of implementing vaccinal control during an epidemic.
Hutber AM; Kitching RP; Fishwick JC; Bires J
Vet J; 2011 Apr; 188(1):18-23. PubMed ID: 20350828
[TBL] [Abstract][Full Text] [Related]
15. Past and present vaccine development strategies for the control of foot-and-mouth disease.
Balamurugan V; Kumar RM; Suryanarayana VV
Acta Virol; 2004; 48(4):201-14. PubMed ID: 15745043
[TBL] [Abstract][Full Text] [Related]
16. Foot-and-mouth disease control using vaccination: South African experience.
Brückner GK; Vosloo W; Cloete M; Dungu B; Du Plessis BJ
Dev Biol (Basel); 2004; 119():51-62. PubMed ID: 15742618
[TBL] [Abstract][Full Text] [Related]
17. The control of foot-and-mouth disease in Botswana: special reference to vaccination.
Letshwenyo M; Fanikiso M; Chimbombi M
Dev Biol (Basel); 2004; 119():403-13. PubMed ID: 15742653
[TBL] [Abstract][Full Text] [Related]
18. Non-capsid proteins to identify foot-and-mouth disease viral circulation in cattle irrespective of vaccination.
Bergmann IE; Malirat V; Neitzert E
Biologicals; 2005 Dec; 33(4):235-9. PubMed ID: 16257539
[TBL] [Abstract][Full Text] [Related]
19. Non-structural protein 3A for differentiation of foot-and-mouth disease infected and vaccinated animals in Haryana (India).
Kumar N; Sharma R; Kakker NK
Zoonoses Public Health; 2007; 54(9-10):376-82. PubMed ID: 18035976
[TBL] [Abstract][Full Text] [Related]
20. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies II: Waiting Periods After Emergency Vaccination in FMD Free Countries.
Geale DW; Barnett PV; Clarke GW; Davis J; Kasari TR
Transbound Emerg Dis; 2015 Aug; 62(4):388-406. PubMed ID: 24131661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
